134 related articles for article (PubMed ID: 37461830)
1. Functional characterization of a rare pathogenic variant c.875G > A, p.(Cys292Tyr) in COMP.
Yin L; Zhu Y; Jiang W; Song Y; Lu Y; Tao D; Liu Y; Ma Y
Ann Hum Genet; 2023 Sep; 87(5):241-247. PubMed ID: 37461830
[TBL] [Abstract][Full Text] [Related]
2. Decreased Plasma COMP and Increased Plasma CTX-II Levels in a Chinese Pseudoachondroplasia Family with Novel
Gu C; Yang Z; Tan H; Zhang Y; Lu Y; Ma Y
Biomed Res Int; 2017; 2017():5809787. PubMed ID: 29104872
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
[TBL] [Abstract][Full Text] [Related]
4. Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasia.
Posey KL; Coustry F; Veerisetty AC; Liu P; Alcorn JL; Hecht JT
J Bone Miner Res; 2014; 29(5):1258-68. PubMed ID: 24194321
[TBL] [Abstract][Full Text] [Related]
5. Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis.
Coustry F; Posey KL; Maerz T; Baker K; Abraham AM; Ambrose CG; Nobakhti S; Shefelbine SJ; Bi X; Newton M; Gawronski K; Remer L; Veerisetty AC; Hossain MG; Chiu F; Hecht JT
Matrix Biol; 2018 Apr; 67():75-89. PubMed ID: 29309831
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic interventions for pseudoachondroplasia.
Posey KL; Hecht JT
Bone; 2017 Sep; 102():60-68. PubMed ID: 28336490
[TBL] [Abstract][Full Text] [Related]
7. Pseudoachondroplasia/COMP - translating from the bench to the bedside.
Posey KL; Alcorn JL; Hecht JT
Matrix Biol; 2014 Jul; 37():167-73. PubMed ID: 24892720
[TBL] [Abstract][Full Text] [Related]
8. Joint Degeneration in a Mouse Model of Pseudoachondroplasia: ER Stress, Inflammation, and Block of Autophagy.
Hecht JT; Veerisetty AC; Hossain MG; Patra D; Chiu F; Coustry F; Posey KL
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502142
[TBL] [Abstract][Full Text] [Related]
9. Health consequences of mutant cartilage oligomeric matrix protein and its relationship to abnormal growth and joint degeneration.
Hecht JT; Chiu F; Veerisetty A; Hossain M; Posey KL
Matrix Biol; 2023 May; 119():101-111. PubMed ID: 37001593
[TBL] [Abstract][Full Text] [Related]
10. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
Merritt TM; Alcorn JL; Haynes R; Hecht JT
J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
[TBL] [Abstract][Full Text] [Related]
11. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
12. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
13. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
[TBL] [Abstract][Full Text] [Related]
14. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.
Suleman F; Gualeni B; Gregson HJ; Leighton MP; Piróg KA; Edwards S; Holden P; Boot-Handford RP; Briggs MD
Hum Mutat; 2012 Jan; 33(1):218-31. PubMed ID: 22006726
[TBL] [Abstract][Full Text] [Related]
15. An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.
Posey KL; Veerisetty AC; Liu P; Wang HR; Poindexter BJ; Bick R; Alcorn JL; Hecht JT
Am J Pathol; 2009 Oct; 175(4):1555-63. PubMed ID: 19762713
[TBL] [Abstract][Full Text] [Related]
16. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH.
Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM
Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasia.
Posey KL; Coustry F; Veerisetty AC; Hossain M; Alcorn JL; Hecht JT
Hum Mol Genet; 2015 Jul; 24(14):3918-28. PubMed ID: 25859006
[TBL] [Abstract][Full Text] [Related]
18. CurQ+, a Next-Generation Formulation of Curcumin, Ameliorates Growth Plate Chondrocyte Stress and Increases Limb Growth in a Mouse Model of Pseudoachondroplasia.
Hecht JT; Veerisetty AC; Hossain MG; Chiu F; Posey KL
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835255
[TBL] [Abstract][Full Text] [Related]
19. Homozygosity for a missense variant in COMP gene associated with severe pseudoachondroplasia.
Tariq M; Khan TN; Lundin L; Jameel M; Lönnerholm T; Baig SM; Dahl N; Klar J
Clin Genet; 2018 Jan; 93(1):182-186. PubMed ID: 28685811
[TBL] [Abstract][Full Text] [Related]
20. A Novel
Guo BB; Jin JY; Yuan ZZ; Zeng L; Xiang R
Biomed Res Int; 2021; 2021():6678531. PubMed ID: 33748277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
